Search for Clinical Trial Results
Hemangiosarcoma - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery Condition: Sarcoma Date: 2009-04-02 Interventions: Drug: sorafenib tosylate |
Completed |
Study Name: Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery Condition: Sarcoma Date: 2005-09-20 Interventions: Drug: paclitaxel |
Active, not recruiting |
Study Name: Bevacizumab in Treating Patients With Angiosarcoma Condition: Sarcoma Date: 2006-02-06 Interventions: Biological: Bevacizumab Bevacizumab 15 mg/kg IV infusion given on day 1 every 21 days = (1 cycle). |
Active, not recruiting |
Study Name: A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas Condition: Soft Tissue Sarcoma Date: 2010-06-08 Interventions: Drug: Axitinib Patients will take axitinib tablets 5 mg by mouth twice daily continuously. There may be |
Not yet recruiting |
Study Name: Evaluation of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization. Condition:
|
Completed |
Study Name: Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Condition:
|
Completed |
Study Name: Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Condition:
Interventions: |
Completed |
Study Name: Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma Condition:
Interventions: |